|
|||
|
Multiple Sclerosis Information
Search
This Month
Favorite Links
Month Archive
|
« Previous
Sunday, April 12
by
All About MS
on Sun 12 Apr 2009 09:48 AM CST
Acorda Therapeutics, Inc. announced today that the Company received a refuse to file letter from the U.S. Food and Drug Administration (FDA) regarding its New Drug Application (NDA) for Fampridine-SR, a novel therapy being developed to improve walking ability more »
Thursday, April 2
by
All About MS
on Thu 02 Apr 2009 10:00 AM CST
The drug 4-aminopyridine (Fampridine) improves walking ability in some patients with multiple sclerosis (MS) and seems to be well tolerated in patients with all disease course types of MS, according to a phase 3 study published more »
|
||